Nourishing and health benefits of coenzyme Q10 - A review

Czech Journal of Food Sciences

Volumn 26, Issue 4, 2008, Pages 229-241

  Boreková, Martina ^a   Hojerová, Jarmila ^a   Koprda, Vasil ^a   Bauerová, Katarína ^b  

^a SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

^b INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

Ageing; Coenzyme Q10; Diseases; Food; Grape; Health benefits; Nourishing; Nutritional supplement; Skin; Ubiquinone; Wine

Indexed keywords

VITACEAE;

EID: 52649149767     PISSN: 12121800     EISSN: None     Source Type: Journal    
DOI: 10.17221/1122-cjfs     Document Type: Review

References (82)

1. ARROYO A., KAGAN V.E., TYURIN V.A., BURGESS J.R., de CABO R., NAVAS P., VILLALBA J.M. (2000): NADH and NADPH dependent reduction of coenzyme Q at the plasma membrane. Antioxidants & Redox Signalling, 2: 251-262.
2. 10 drug surveillance investigators. Molecular Aspects of Medicine, 15: 287-294.
3. BATTINO M., FERRI E., GORINI A., VILLA F.R., HUERTAS R.J.F., FIORELLA P., GENOVA M.L., LENAZ G., MARCHETTI M. (1990): Natural distribution and occurrence of coenzyme Q homologues. Membrane Biochemistry, 9:179-190.
4. BAUEROVÁ K., BEZEK Š. (1999): Role of reactive oxygen and nitrogen species in ethiopathogenesis of rheumatoid arthritis. General Physiology and Biophysics, 18: 15-20.
5. 10 supplementation in adjuvant arthritis (pre-clinical study). In: GVOZDJÁKOVÁ A. (ed.): Mitochondrial Medicine. Springer, the Netherlands. BENTINGER M., BRISMAR K., DALLNER G. (2007): The antioxidant role of coenzyme Q. Mitochondrion, 7 (Suppl. 1): S41-S50.
6. 10: Absorption, tissue uptake, metabolism and pharmacokinetics. Free Radical Research, 40: 445-453.
7. COMSTOCK G.W., BURKE A.E., HOFFMAN S.C., HELZLSOUER K.J., BENDICH A., MASI A.T., NORKUS E.P., MALAMENT R.L., GERSHWIN M.E. (1997): Serum concentrations of alpha-tocopherol, beta-carotene, and retinol proceeding the diagnosis of rheumatoid arthritis and systemic lupus erythematosus. Annals of the Rheumatic Diseases, 56: 323-325.
8. 10. Journal of the American College of Nutrition, 20: 591-598.
9. CRANE F.L., HATEFI Y., LESTER R.L., WIDMER C. (1957): Isolation of a quinone from beef heart and beef heart mitochondria. Biochimica et Biophysica Acta, 25: 220-221.
10. CRANE F.L., SUN I.L., BARR R., MORRE D.J. (1984): Coenzyme Q in Golgi apparatus membrane redox activity and proton uptake. In: FOLKERS K., YAMAMURA Y. (eds): Biomedical and Clinical Aspects of Coenzyme Q. Elsevier Science, Amsterdam: 77-86.
11. 10 on essential arterial hypertension. Current Therapeutic Research, Clinical and Experimental, 47: 841-845.
12. 10 administration on metabolic control in patients with type 2 diabetes mellitus. Biofactors, 9: 315-318.
13. 10 in the mitochondria. In: FOLKERS K., YAMAMURA Y. (eds): Biomedical and Clinical Aspects of Coenzyme Q. Elsevier Science, Amsterdam: 15-18.
14. ERNSTER L., DALLNER G. (1995): Biochemical, physiological and medical aspects of ubiquinone function. Biochimica et Biophysica Acta, 1271:195-204.
15. FESTENSTEIN G.N., HEATON F.W., LOWE J.S., MORTON R. A. (1955): A constituent of the unsaponifiable portion of animal tissue lipids. Biochemical Journal, 59: 558-566.
16. 10. Biochemical and Biophysical Research Communications, 192: 241-245.
17. 10 of patients in heart failure who are eligible or ineligible for a transplant. Biochemical and Biophysical Research Communications, 182: 247-253.
18. 10 in animal models and a serious deficiency in patients with cancer. Biochemical and Biophysical Research Communications, 234: 296-299.
19. FORSMARK-ANDREE P., DALLNER G., ERNSTER L. (1995): Endogenous ubiquinol prevents protein modification accompanying lipid peroxidation in beef heart submitochondrial particles. Free Radical Biology & Medicine, 19: 749-757.
20. 10 in asthmatics. Bratislavské lekárske listy, 103: 353-356.
21. 10 A new drug for cardiovascular disease. Journal of Clinical Pharmacology, 7: 596-608.
22. 10 in plasma. Journal of Chromatography, 593:217-226.
23. GVOZDJÁKOVÁ A., KUCHARSKÁ J., ĎURIŠIN P., MINÁRIK E. (1996): Is plastoquinone 10-OX an antioxidant marker of red wines? Vitis, 35:103-104.
24. 10 Association, Los Angeles, April 14-17, 2005: 108-109.
25. 10 Association, Frankfurt, December 1-3, 2000:108-110.
26. 10 depletion and mitochondrial energy disturbances in rejection development in patients after transplantation. Biofactors, 9: 301-306.
27. 10 supplementation differently modulated heart and skeletal muscle mitochondrial function induced by adjuvant arthritis. In: Mitochondrial Medicine 2004 Meeting, Pittsburgh, August 4-7, 2004 (Abstracts). Mitochondrion, 4: 20-21.
28. nd General Assembly of the International Office of Vine and Wine, Bratislava, June 24-28, 2002:1-13.
29. 10 on adult periodontitis. Molecular Aspects of Medicine, 15: 241-248.
30. 10) treatment on glycaemic control, insulin requirement and well-being in patients with type 1 diabetes mellitus. Diabetic Medicine: a Journal of the British Diabetic Association, 16: 312-318.
31. 10. In: Proceeedings International Conference of Cosmetology, Olomouc, November 9-11,1999: 33-35.
32. 10- význam, vlastnosti a využitie vo výžive a kozmetike. Česka a slovenská; farmacie, 49: 119-123.
33. HOJEROVÁ J., BOREKOVÁ M., KOŠŤÁLOVÁ D., BAUEROVÁ K. (2006): Oxidative skin stress-the important etiopathogenetic factor. In: Proceedings International Conference of Cosmetology, Bratislava, October 4-6, 2006: 115-119.
34. HOPPE U., BERGEMANN J., DIEMBECH W., ENNEN J., GOHLA S., HARRIS I., JACOB J., KIELHOLZ J., MEI W., POLLET D., S CHACHTSCHABEL D., SUERMANN G., SCHREINER V., STAB F., STECKEL F. (1999): Coenzyme Q, a cutaneous antioxidant and energizer. Biofactors, 9: 371-378.
35. 10 and differences in coronary heart disease risk in Asian Indians and Chinese. Free Radical Biology and Medicine, 32: 132-138.
36. 10. Elsevier Science, Amsterdam: 109-119.
37. 10. Archives of Biochemistry and Biophysics, 423: 47-56.
38. JASWAL S., MEHTA H.C., SOOD A.K., KAUR J. (2003): Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clinica Chimica Acta, 338: 123-129.
39. JOSHI S.S., SAWANT S.V., SHEDGE A., HALPNER A.D. (2003): Comparative bioavailability of two novel coenzyme Q10 preparations in humans. The International Journal of Clinical Pharmacology and Therapeutics, 41: 42-48.
40. KAGAN V, SERBINOVÁ E., PACKER L. (1990): Antioxidant effects of ubiquinones in microsomes and mitochondria are mediated by tocopherol recycling. Biochemical and Biophysical Research Communications, 169: 851-857.
41. 10: Absorption, antioxidative properties, determinants and plasma levels. Free Radical Research, 36: 389-397.
42. KAMEI M., FUJITA T., KANBE T., SASAKI K., OSHIPA K., OTANI S., MATSUI-YUASA I., MORISAWA S. (1986): The distribution and content of ubiquinone in foods. International Journal for Vitamin and Nutrition Research, 56: 57-63.
43. KNEKT P., HELIOVAARA M., AHO K., ALFTHAN G., MARNIEMI J., AROMAA A. (2000): Serum selenium, serum alpha-tocopherol, and the risk of rheumatoid arthritis. Epidemiology, 11: 402-405.
44. KOPRDA V., BUJNOVÁ A., KUCHARSKÁ J., GVOZDJÁKOVÁ A., KUNHARTOVÁ E., SABOLOVÁ D. (2005): Štúdium prechodu koenzýmu Q1O cez kožu (Abstrakt). 32. Technologické dni, Bratislava, September 8-9, 2005. Farmaceutický Obzor, LXXIV: 216.
45. 10 Association, Los Angeles, April 14-17, 2005:110-112.
46. LANG J.K., PARCKER L. (1987): Quantitative determination of vitamin E and oxidized and reduced coenzyme Q by HPLC with in-line ultraviolet and electrochemical detection. Journal of Chromatography, 385: 109-117.
47. LASS A., SOHAL R.S. (1998): Electron transport-linked ubiquinone-dependent recycling of alpha-tocopherol inhibits autooxidation of mitochondrial membranes. Archives of Biochemistry and Biophysics, 352: 229-236.
48. 10 levels, plasma lipids and peroxidation extent in renal failure and in hemodialytic patients. Molecular Aspects of Medicine, 15: 213-219.
49. 10 in biology and medicine. Casa Editrice Scientifica Internazionale: 1-91.
50. 10 in human heart disease. Part I and II. International Journal for Vitamin and Nutrition Research, 42/2: 291, 42/3: 413.
51. 10 levels. In: FOLKERS K., YAMAGAMI T., LITTARRU G.P. (eds): Biomedical and Clinical Aspects of Coenzyme Q. Elsevier Science, Amsterdam: 167-178.
52. 10 in gingival tissue from patients with periodontal disease. Proceedings the National Academy of Sciences of the United States of America, 68: 2332-2335.
53. 10. Molecular Aspects of Medicine, 15: 231-240.
54. 10. Biochemical and Biophysical Research Communications, 199: 1504-1508.
55. 10: Contents in foods and dietary intake. Journal of Food Composition and Analysis, 14: 409-417.
56. MELLORS A., TAPPEL A.L. (1966a): Quinones and quinols as inhibitors of lipid peroxidation. Lipids, 1: 282-284.
57. MELLORS A., TAPPEL A.L. (1966b): The inhibition of mitochondrial peroxidation by ubiquinone and ubiquinol. Journal of Biological Chemistry, 241: 4353-4356.
58. 10 reference intervals, but not redox status, are affected by gender and race in self-reported healthy adults. Clinica Chimica Acta, 332: 123-132.
59. MITCHELL M. (1961): Coupling of phosphorylation to electron and hydrogen transfer by a chemiosmotic type of mechanism. Nature, 191:144-148.
60. MITCHELL M. (1966): Chemiosmotic coupling in oxidative and photosynthetic phosphorylation. Biological Reviews Cambridge Philosophical Society, 41: 445-502.
61. 10 in diabetic patients. Arzneimittel-Forschung, 49: 324-329.
62. 10 (ubiquinone). The Clinical Investigator, 71:116-123.
63. 10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease. Neuroscience Letters, 341: 201-204.
64. OLSON R.E. (2001): Karl August Folkers. Journal of Nutrition, 131: 2227-2230.
65. 10 in health and disease. European Journal of Clinical Nutrition, 53: 764-770.
66. POON W.W., DO T.Q., MARBOIS B.N., CLARKE C.F. (1997): Sensitivity to treatment with polyunsaturated fatty acids is a general characteristic of the ubiquinone-deficient yeast coq mutants. Molecular Aspects of Medicine, 18: 121-128.
67. 10 deficiency. Neurochemical Research, 32: 723-727.
68. RAMASARMA T. (1985): Natural Occurrence and Distribution of Coenzyme Q. In: LENAZ G. (ed.): Coenzyme Q. Biochemistry, Biogenetics and Clinical Applications of Ubiquinone. John Wiley and Sons, New York: 67-81.
69. SHINDO Y., WITT, E., HAN D., PACKER L. (1994): Dose-response effects of acute ultraviolet irradiation on antioxidants and molecular markers of oxidation in murine epidermis and dermis. Journal of Investigative Dermatology, 102: 470-475.
70. 10, vitamin E and dihydrothioctic acid cooperatively prevent diene conjugation in isolated low density lipoprotein. Antioxidants & Redox Signaling, 2: 327-333.
71. 10 in the etiology and treatment of Parkinson's disease. Biofactors, 9: 267-272.
72. 10 in early Parkinson disease: Evidence of slowing of the functional decline. Archives of Neurology, 59:1523.
73. 10 in chronic renal failure: Discovery of a new role. Journal of Nutritional and Environmental Medicine, 10: 281-288.
74. TAKAHASHI S., OGIYAMA Y., KUSANO H., SHIMADA H., KAWAMUKAI M., KADOWAKI K. (2006): Metabolic engineering of coenzyme Q by modification of isoprenoid side chain in plant. FEBS Letters, 580: 955-959.
75. 10 in human plasma. Clinical Chemistry, 47: 256-265.
76. THOMAS S.R., WITTING P.K., STOCKER R. (1999): A role for reduced coenzyme Q in atherosclerosis. Biofactors, 9: 207-224.
77. 10 ubiquinone. US patent 6,506,915.
78. 10 soft gel capsules. US patent 6,855,733.
79. 10 after a single dose and after long-term supplementation in the skin of young and middle-aged subjects. International Journal of Cosmetic Science, 28:148-148.
80. 10 content of the average Danish diet. International Journal for Vitamin and Nutrition Research, 67:123-129.
81. 10 on essential hypertension, a double blind controlled study. In: FOLKERS K., LITTARRU G., YAMAMURA Y. (eds): Biomedical and Clinical Aspects of Coenzyme Q. Elsevier Science, Amsterdam: 337-343.
82. 10 nanoemulsions. Cosmetic Science and Technology, 1: 1-7.